« Back

Foster City, Calif -- March 7, 2007 -- Scale Venture Partners (formerly BA Venture Partners) announced today that it has completed a final close on Scale Venture Partners II, a $400 million fund. The Scale Venture Partners team employs a thesis-based strategy to identify innovative development-stage technology and healthcare investments, and collaborates with its portfolio companies to accelerate their growth. Due to a significant response to the offering, original limited partner Bank of America agreed to transfer its interest in Fund II entirely, allowing Scale Venture Partners to build a portfolio of twelve long-term Limited Partners. Bank of America continues to be the sole limited partner for Scale Venture Partners I, a $500 million fund.

"Throughout our fundraising process, we heard that the team and our thesis-based approach to investing were important differentiators," said Kate Mitchell, Managing Director with Scale Venture Partners. "It was gratifying to generate such strong interest, which was a nice validation of our approach to investing and our top-quartile results. We look forward to a long-term partnership with our new Limited Partners, and thank Bank of America for its support throughout the process."

Limited Partners in Scale Venture Partners Fund II include Credit Suisse, Key Capital Corporation, Lexington Partners, Liberty Mutual, Macquarie Global Private Equity Fund, Montague Newhall, Pantheon Ventures and its affiliates, Paul Capital Partners, Storebrand, and several other domestic and international institutional investors. Probitas Partners served as placement agent for the fund.

Since 2000, the ScaleVP team has delivered top-quartile results by implementing a thesis-based approach to investing in technology and healthcare companies. The team prefers to invest at the turning point when companies need expertise to help them significantly increase the growth of their business. The ScaleVP team has consistently focused on identifying companies that take innovative approaches to addressing market opportunities in sectors such as consumer electronics, software-as-a-service, and healthcare companies that are repurposing already approved drugs.

About Scale Venture Partners
Scale Venture Partners employs a thesis-based strategy to identify innovative development-stage technology and healthcare investments. The ScaleVP team works with technology and healthcare companies to accelerate their growth and become more valuable to entrepreneurs, investors and consumers. Based in Foster City, California, the ScaleVP team collectively offers decades of technology and venture industry experience to development-stage companies in hardware, software, healthcare and medical devices. Representative portfolio companies include Alimera, Frontbridge, Glu Mobile, Good Technology, Monolithic Power Systems, Omniture, Orexigen, Placeware, ScanSafe, Seattle Genetics, Somaxon, Wayport and Xceive. For more information, visit www.scalevp.com

« Back